Morbidity and mortality with early pulmonary haemorrhage in preterm neonates

Arch Dis Child Fetal Neonatal Ed. 2019 Jan;104(1):F63-F68. doi: 10.1136/archdischild-2017-314172. Epub 2018 Jan 27.

Abstract

Objective: There are no large studies evaluating pulmonary haemorrhage (PH) in premature infants. We sought to quantify the clinical characteristics, morbidities and mortality associated with early PH.

Design: Data were abstracted from the Pediatrix Clinical Data Warehouse, a large de-identified data set. For incidence calculations, we included infants from 340 Pediatrix United States Neonatal Intensive Care Units from 2005 to 2014 without congenital anomalies. Infants <28 weeks' gestation with PH within 7 days of birth were then matched with two controls for birth weight, gestational age, gender, antenatal steroid exposure, day of life 0 or 1 intubation and multiple gestation.

Results: From 596 411 total infants, we identified 2799 with a diagnosis of PH. Peak incidence was 86.9 cases per 1000 admissions for neonates born at 24 weeks' gestation. We then identified 1476 infants <28 weeks' gestation with an early PH diagnosis at ≤7 days of age of which 1363 (92.3%) were successfully matched. Patients with early PH had significantly higher exposure to poractant alfa (35.4% vs 28%), diagnosis of shock (63.7% vs 51%) and grade IV intraventricular haemorrhage (20.8% vs 6%). Patients with PH also had significantly higher mortality rates at 7 days of age (40.6% vs 18.9%), 30 days of age (54% vs 28.8%) and prior to discharge (56.9% vs 33.7).

Conclusion: In this large cohort of premature infants, we found PH to be common among the most premature babies. Early PH was associated with significant morbidity and mortality in excess of 50%. A renewed focus on the underlying pathophysiology and prevention of PH is warranted.

Keywords: neonatology; respiratory.

Publication types

  • Multicenter Study

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Biological Products / administration & dosage
  • Birth Weight
  • Female
  • Gestational Age
  • Hemorrhage / mortality*
  • Humans
  • Infant
  • Infant Mortality
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases / mortality*
  • Intensive Care Units, Neonatal
  • Lung Diseases / mortality*
  • Male
  • Phospholipids / administration & dosage
  • Pulmonary Surfactants / administration & dosage
  • Retrospective Studies
  • Severity of Illness Index
  • Sex Factors
  • United States

Substances

  • Adrenal Cortex Hormones
  • Biological Products
  • Phospholipids
  • Pulmonary Surfactants
  • poractant alfa